Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.

CONCLUSIONS: Very low quality evidence suggests that oromucosal nabiximols and THC have no effect on pain, sleep problems and opioid consumption in patients with cancer pain with insufficient pain relief from opioids. The complete manuscript is written in English. PMID: 31073761 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31073761?dopt=Abstract

Source: Schmerz - May 8, 2019 Category: Anesthesiology Authors: Häuser W, Welsch P, Klose P, Radbruch L, Fitzcharles MA Tags: Schmerz Source Type: research